---
title: "Parnax Lab Ltd (506128) — Share Price, Financials & Analysis"
symbol: "506128"
company: "Parnax Lab Ltd"
canonical: "https://tapetide.com/stocks/506128"
isin: "INE383L01019"
nse_symbol: "PARNAXLAB"
bse_code: "506128"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 143.57
generated_at: "2026-09-13T18:39:51.771Z"
---

# Parnax Lab Ltd (506128)

Canonical page: https://tapetide.com/stocks/506128

## Company

- **NSE Symbol:** PARNAXLAB
- **BSE Code:** 506128
- **ISIN:** INE383L01019
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2026-08-17
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** naxparlab.com

## About

Incorporated in 1985, Parnax Lab Ltd manufactures and exports Pharmaceutical Formulations[1]

## Latest Price

- **Price:** ₹127
- **Change:** -0.48 (-0.38%)
- **Open:** ₹127.48
- **Day High:** ₹134.72
- **Day Low:** ₹125
- **Previous Close:** ₹127.48
- **Volume:** 3083
- **As Of:** 2026-09-11T09:52:51+00:00

## Key Fundamentals

Observed at 2026-09-11T04:42:42.412816Z.

- **Market Cap:** ₹143.57 Cr
- **Classification:** Microcap
- **P/E (reported):** 16.9
- **P/E (TTM):** 16.3
- **EPS (TTM):** ₹7.79
- **Book Value:** ₹82.83
- **Price to Book:** 1.59
- **Dividend Yield:** 0%
- **ROE:** 13.86%
- **ROCE:** 18.24%
- **Debt to Equity:** 0.87
- **Revenue (yearly):** ₹248.54 Cr
- **Net Income:** ₹12.28 Cr
- **EBITDA:** ₹25.88 Cr
- **52-Week High:** ₹149.5
- **52-Week Low:** ₹104
- **RSI (14):** 72.25

## Tapetide Score

- **Score:** 55 / 100
- **Score date:** 2026-09-04
- **Archetype:** Quality at a Reasonable Price
- **What it means:** Financial strength is not being paid for with a demanding multiple. The question worth asking is whether the quality is durable or reflects a good patch — check the consistency of returns over several years rather than the latest quarter.
- **Pillar profile:** Quality: Good · Valuation: Fair · Momentum: Rising
- **Percentile:** 70.1 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 26.2 | 9% |
| growth | 79.72 | 9% |
| momentum | 60.57 | 12% |
| ownership | 50 | 24% |
| quality | 63.72 | 22% |
| valuation | 54.7 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is expected to give good quarter

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company might be capitalizing the interest cost

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 103.4% | 54.47% | 411.89% |
| ebitda margin growth | -33.33% | -31.69% | -20.16% | -28.25% |
| net income growth | -81.82% | 6.78% | 14% | 105% |
| revenue growth | -20.53% | 31.22% | 14% | 23% |
| roce | -51.41% | 12.11% | -13.18% | 17.86% |
| roe | -80.28% | 3.28% | 13.72% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 42.61 | 50.99 | 46.37 | 50.12 | 48.36 | 40.22 | 49.04 | 53.38 | 62.6 | 62.94 | 69.63 | 56.8 |
| Expenses | 37.32 | 45.02 | 40.58 | 41.5 | 41.12 | 35.95 | 42.41 | 45.94 | 54.52 | 56.09 | 64.75 | 52.49 |
| Operating Profit | 5.29 | 5.97 | 5.79 | 8.62 | 7.24 | 4.27 | 6.63 | 7.44 | 8.08 | 6.85 | 4.88 | 4.31 |
| OPM % | 12.41 | 11.71 | 12.49 | 17.2 | 14.97 | 10.62 | 13.52 | 13.94 | 12.91 | 10.88 | 7.01 | 7.59 |
| Other Income | 0.22 | 0.1 | 0.25 | 0.11 | 0.95 | 0.19 | 0.43 | 0.18 | 0.63 | -0.17 | 1.76 | 0.15 |
| Interest | 1.43 | 1.35 | 1.41 | 1.5 | 1.38 | 1.23 | 1.28 | 1.22 | 1.4 | 1.47 | 1.61 | 1.64 |
| Depreciation | 1.74 | 1.78 | 1.84 | 1.83 | 1.94 | 1.79 | 1.83 | 1.94 | 2.1 | 1.96 | 2.04 | 2.22 |
| Profit before tax | 2.34 | 2.94 | 2.79 | 5.4 | 4.87 | 1.44 | 3.95 | 4.46 | 5.21 | 3.25 | 2.99 | 0.6 |
| Tax % | 20.09 | 25.85 | 19.35 | 26.3 | 29.77 | 16.67 | 26.08 | 26.46 | 30.33 | 16.62 | 27.09 | 28.33 |
| Net Profit | 1.87 | 2.18 | 2.24 | 3.99 | 3.42 | 1.21 | 2.93 | 3.28 | 3.62 | 2.71 | 2.19 | 0.43 |
| EPS in Rs | 1.63 | 1.9 | 1.95 | 3.47 | 2.97 | 1.05 | 2.54 | 2.85 | 3.16 | 2.36 | 1.9 | 0.37 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 106 | 109 | 95 | 90 | 163 | 168 | 189 | 188 | 249 | 252 |
| Expenses | 95 | 99 | 89 | 80 | 140 | 145 | 165 | 161 | 221 | 228 |
| Operating Profit | 10 | 10 | 6 | 10 | 23 | 23 | 24 | 27 | 27 | 24 |
| OPM % | 10 | 9 | 7 | 11 | 14 | 14 | 12 | 14 | 11 | 10 |
| Other Income | 1 | 2 | 1 | 0 | 0 | 1 | 1 | 1 | 2 | 2 |
| Interest | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 6 |
| Depreciation | 4 | 4 | 4 | 5 | 6 | 7 | 7 | 7 | 8 | 8 |
| Profit before tax | 3 | 5 | -2 | 0 | 12 | 12 | 12 | 16 | 16 | 12 |
| Tax % | 65 | 28 | 48 | 350 | 33 | 30 | 20 | 26 | 26 | — |
| Net Profit | 1 | 3 | -3 | 0 | 8 | 9 | 10 | 12 | 12 | 9 |
| EPS in Rs | 1.23 | 3.88 | -3.42 | -0.42 | 8.4 | 7.51 | 8.37 | 10.03 | 10.26 | 7.79 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 8 | 8 | 8 | 8 | 8 | 10 | 11 | 11 | 11 | 11 |
| Reserves | 23 | 24 | 27 | 24 | 24 | 38 | 51 | 60 | 72 | 84 |
| Borrowings | 39 | 37 | 42 | 51 | 59 | 69 | 55 | 81 | 70 | 83 |
| Other Liabilities | 15 | 18 | 17 | 23 | 15 | 36 | 28 | 38 | 37 | 50 |
| Total Liabilities | 86 | 87 | 95 | 107 | 106 | 153 | 145 | 190 | 190 | 228 |
| Fixed Assets | 47 | 44 | 51 | 58 | 60 | 72 | 77 | 89 | 88 | 115 |
| CWIP | 0 | 0 | 0 | 3 | 5 | 3 | 2 | 21 | 29 | 11 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 38 | 43 | 43 | 46 | 41 | 78 | 66 | 80 | 72 | 101 |
| Total Assets | 86 | 87 | 95 | 107 | 106 | 153 | 145 | 190 | 190 | 228 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 16 | 13 | 9 | 9 | 6 | 9 | 21 | 16 | 32 | 8 |
| Cash from Investing Activity | -10 | -5 | -11 | -13 | -7 | -16 | -10 | -32 | -16 | -16 |
| Cash from Financing Activity | -5 | -7 | 1 | 5 | 0 | 12 | -14 | 15 | -16 | 8 |
| Net Cash Flow | 0 | 1 | -1 | 0 | 0 | 4 | -3 | -1 | 0 | 0 |
| Free Cash Flow | 5 | 8 | -3 | -4 | 0 | -8 | 11 | -16 | 16 | -9 |
| CFO/OP | 134 | 134 | 99 | 153 | 71 | 38 | 103 | 79 | 130 | 42 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 72 | 65 | 64 | 88 | 68 | 85 | 61 | 63 | 60 | 56 |
| Inventory Days | 50 | 45 | 52 | 76 | 80 | 73 | 79 | 94 | 87 | 90 |
| Days Payable | 48 | 45 | 44 | 74 | 46 | 81 | 53 | 74 | 72 | 80 |
| Cash Conversion Cycle | 74 | 64 | 72 | 90 | 102 | 77 | 86 | 83 | 75 | 65 |
| Working Capital Days | -26 | -8 | 0 | -31 | -66 | -35 | -19 | -23 | -24 | -11 |
| ROCE % | 14 | 11 | 12 | 3 | 6 | 17 | 15 | 13 | 14 | 14 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 72.3% | 72.3% | 72.3% | 72.3% | 72.3% | 72.3% | 72.3% | 72.3% | 72.3% | 72.3% | 72.3% | 72.3% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 24.88% | 24.46% | 24.45% | 24.6% | 24.26% | 24.68% | 24.73% | 24.97% | 24.93% | 24.37% | 23.27% | 22.71% |
| Others | 2.83% | 3.25% | 3.26% | 3.11% | 3.44% | 3.02% | 2.97% | 2.74% | 2.77% | 3.33% | 4.44% | 5% |
| No. of Shareholders | 3543 | 3536 | 4496 | 4406 | 4173 | 4521 | 4440 | 4317 | 4111 | 3900 | 3721 | 3572 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 3 / 6 / 10

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 132.37 | Sell |
| EMA (10) | 129.81 | Sell |
| SMA (20) | 128.23 | Sell |
| EMA (20) | 130.36 | Sell |
| SMA (50) | 135.54 | Sell |
| EMA (50) | 133.23 | Sell |
| SMA (100) | 140.57 | Sell |
| EMA (100) | 135.09 | Sell |
| SMA (200) | 133.18 | Sell |
| EMA (200) | 132.42 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 45.45 | Neutral |
| MACD (12,26,9) | -0.99 | Buy |
| Stochastic (14,3,3) | 50.69 | Neutral |
| ADX (14) | 16.83 | Neutral |
| Williams %R (14) | -49.45 | Neutral |
| ATR (14) | 11.69 | High Volatility |
| ROC (12) | 2.66 | Buy |
| Stoch RSI (14) | 19.56 | Buy |
| UO (7,14,28) | 51.68 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-07 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e013bc01-95c6-436a-8b1d-761bf0e5b7e7.pdf) |
| 2026-09-07 | [Notice Of 44Th AGM Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c31070b6-0a9f-41a2-9f1f-6fcbed43d09a.pdf) |
| 2026-09-07 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83f6a8e1-6cc8-4307-bc8d-1de14c6eb0e3.pdf) |
| 2026-08-26 | [Board Meeting Outcome for Outcome Of BM Held Today I.E. 26Th August 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d04313bb-4365-48b7-b084-d58fe86fb0b6.pdf) |
| 2026-08-26 | [Notice Of Book Closure](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8da84f00-341c-48dd-bd55-0615f51b9993.pdf) |
| 2026-08-14 | [Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2AEF1F98_8F97_41A3_94CE_2A479B88102E_104014.pdf) |
| 2026-08-14 | [Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0E61B433_C49F_443D_951E_7C8D18483DF1_105207.pdf) |
| 2026-08-14 | [Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53362486_A822_43D5_BDC6_37A00B7B5790_115951.pdf) |
| 2026-08-14 | [Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8EC0757D_BF9E_4ED0_BA27_9BEDDD0A3F36_120556.pdf) |
| 2026-08-14 | [Board Meeting Outcome for Board Meeting Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=82e51f24-6b1b-4d9b-8de1-d9abdb2be3a8.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-14 | [Financials Results For The Quarter And Three Months Ended June 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8ff2c49-f8fb-47d4-97b2-ca7cd81f2fbb.pdf) |
| 2026-05-28 | [Results For The Quarter And Year Ended March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=04b01f0c-26fa-4977-8b1a-74ebe0f847e3.pdf) |
| 2026-02-13 | [Financial Results For The Quarter Ended December 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a052f41-a9ed-4612-932d-d4ffd6b08d08.pdf) |
| 2026-02-13 | [Financial Results For The Quarter Ended December 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69b0483e-02f6-46ba-b32f-df37585c64ef.pdf) |
| 2025-11-14 | [Results For The Quarter Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62917d92-b3f3-4684-8b1c-99303aa9cc0d.pdf) |
| 2025-08-13 | [Financial Results For The Quarter Ended June 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6cdb8d9-8c86-450e-90e5-f90595028de1.pdf) |
| 2025-05-27 | [Financial Results For The Quarter And Year Ended March 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c295521-870c-42f0-abc3-47aac9cbd9a1.pdf) |
| 2025-02-10 | [Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2da75ee-78ca-403b-8df9-463d5bc58018.pdf) |
| 2024-11-14 | [Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74189eb7-c309-4c8e-b90e-2cd46219a193.pdf) |
| 2024-08-14 | [Financial Results For The Quarter And Three Months Ended June, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ec48c3f-c94c-4ea3-b2e3-db61bc0b0f8e.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 8 Oct 2025 - Registrar certifies Regulation 74(5) non-applicable for quarter ended Sep 30, 2025; all shares in demat. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Oct 2025 - Registrar certifies Regulation 74(5) non-applicable for quarter ended Sep 30, 2025; all shares in demat.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f43f60de-2e6b-4dba-bf77-8a56a283ebcd.pdf) |
| 8 Apr - Parnax Lab reports no dematerialization requests for quarter ended 31 March 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Apr - Parnax Lab reports no dematerialization requests for quarter ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/557fbf9b-3b5b-4911-8dcc-1785ef80b0f0.pdf) |
| 5 Jan - In Accordance with Regulation 74(5) of SEBI (DP) Regulation, 2018 we are enclosing herewith Certificate received from RTA for Quarter 31st December, 2025 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 5 Jan - In Accordance with Regulation 74(5) of SEBI (DP) Regulation, 2018 we are enclosing herewith Certificate received from RTA for Quarter 31st December, 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7f38d87f-5ef5-4dca-8961-e63d93bba501.pdf) |
| 5 Feb - Board meeting on 13 Feb 2026 to approve Q3 and nine-month unaudited financials ended 31 Dec 2025; trading window closed. | [Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Un-Audited Financial Results Along With Limited Review Report For The Quarter (Q3) And Nine Months Ended 31St December, 2025. 5 Feb - Board meeting on 13 Feb 2026 to approve Q3 and nine-month unaudited financials ended 31 Dec 2025; trading window closed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8b06f277-5f81-41e6-902d-14223c089e60.pdf) |
| 3 Nov 2025 - Board meeting on 10 Nov 2025 to approve H1 unaudited results (30 Sep 2025); trading window closed from 1 Oct. | [Board Meeting Intimation for Intimation Of Board Meeting 3 Nov 2025 - Board meeting on 10 Nov 2025 to approve H1 unaudited results (30 Sep 2025); trading window closed from 1 Oct.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/30d40c37-1e7d-49f7-a097-67e94ae5c89c.pdf) |
| 27 Mar - Trading window closed from 01-Apr-2026; reopens 48 hours after audited results for year ended 31-Mar-2026. Checklist: - Read and parse announcement contents - Identify regulatory … | [Closure of Trading Window 27 Mar - Trading window closed from 01-Apr-2026; reopens 48 hours after audited results for year ended 31-Mar-2026. Checklist: - Read and parse announcement contents - Identify regulatory …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/980be4e8-8849-4063-b060-9255f5483633.pdf) |
| 22 Jan - Compliance Certificate under Reg 74 (5) of SEBI (DP) Regulations, 2018 for quarter ended 31st December, 2025 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 22 Jan - Compliance Certificate under Reg 74 (5) of SEBI (DP) Regulations, 2018 for quarter ended 31st December, 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/22806b28-8a62-4126-ae3d-34cf7c619822.pdf) |
| 13 Feb - Board approved unaudited Q3 and nine-month results to 31-12-2025; consolidated revenue Rs 18,070.63 lakhs; exceptional Rs 113.80 lakhs. | [Board Meeting Outcome for Outcome Of Board Meeting 13 Feb - Board approved unaudited Q3 and nine-month results to 31-12-2025; consolidated revenue Rs 18,070.63 lakhs; exceptional Rs 113.80 lakhs.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3e450e4a-c0e2-46e8-bcde-d774ff973510.pdf) |
| 13 Feb - Approved unaudited Q3 and nine-month results (ended 31-Dec-2025); consolidated revenue Rs6,391.30L; exceptional charge Rs113.80L. | [Financial Results For The Quarter Ended December 31, 2025. 13 Feb - Approved unaudited Q3 and nine-month results (ended 31-Dec-2025); consolidated revenue Rs6,391.30L; exceptional charge Rs113.80L.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7a052f41-a9ed-4612-932d-d4ffd6b08d08.pdf) |
| 13 Feb - Approved Q3 and 9M results to 31‑Dec‑2025; consolidated 9M revenue Rs18,070.63L; exceptional expense Rs113.80L. | [Financial Results For The Quarter Ended December 31, 2025. 13 Feb - Approved Q3 and 9M results to 31‑Dec‑2025; consolidated 9M revenue Rs18,070.63L; exceptional expense Rs113.80L.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/69b0483e-02f6-46ba-b32f-df37585c64ef.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0b3f1b14-5830-42fe-85f0-745f5df7fbd3.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a8450a19-7d74-495e-9562-86da708a663a.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b048bb94-054c-403e-a11e-23faddb46770.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a44a40af-db5d-45a0-a604-04a3c4de72bc.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/72f2c24e-fb52-4d41-866f-f5a081dd8d73.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/506128/76508506128.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/506128/72050506128.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/506128/66591506128.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/506128/5061280319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/506128/5061280318.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:39:51.771Z.